7.11.25
9 min. Read

Digital mental health G code adoption “slow and challenging”

Issue 249

Welcome back to E&O: SaMD, a paying subscribers-only weekly newsletter focused on the world of digital pharma products, prescription digital therapeutics and other FDA-regulated digital health.

 E&O: Software as a Medical Device

 


Two quick things before we dig into the "slow and challenging" rollout of the new digital mental health G Codes, a slew of new FDA clearances, as well as the latest updates on digital health-related

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Help me get ahead. $200/year

Newsletters

Filter by
All Selling to Employers Prescription Digital Therapeutics National Virtual Clinics
    402 articles
  • First
  • Previous
    • 1 of 41
  • Next
  • Last
Big Health’s 2024 revenue shrinks. 2025: Runway worries.
9.26.25
5 min. Read
Kavira Health pricing. What did Swing Therapeutics buy? PFS Comments.
9.18.25
7 min. Read
Cerebral’s $25M M&A. Amazon-Fay. Oshi growth numbers.
9.12.25
4 min. Read
Letters to CMS: DMHT codes, MDPP pricing, more. Plus: Unannounced funding.
9.05.25
6 min. Read
Pricing updates: Teladoc, Maven, Garner, Kaia and more
8.29.25
4 min. Read
Pricing for Aetna Transform and 2nd.MD. Teladoc on PFS. Plus: Secret funding.
8.22.25
7 min. Read
New wearable BP 510(k) sheds light on Whoop-FDA. Trials: BetterHelp, Click, DynamiCare, Axena, Kaiser
8.08.25
8 min. Read
CMS RFI review: 12 ideas from health tech cos
7.25.25
10 min. Read
CMS proposes changes to digital mental health G codes, four year test of online DPP reimbursement.
7.16.25
10 min. Read
FDA clears Lumosity-maker’s DTx for ADHD. Withings 510(k) for ECG app.
6.16.25
5 min. Read
  • First
  • Previous
    • 1 of 41
  • Next
  • Last